Practice Home Page
Practice Home Page Programs      Benefits      Research      FAQs       About      Contact
 

 

JCAHO Accredited
  

 

Why You Should Have an Integrated Sleep Lab in Your Practice

There are a number of reasons why an integrated sleep lab makes sense for both your patients and your practice.
 

 PREVALENCE & CONDITIONS


How many of your patients suffer from OSA?

  • 35% of the general cardiovascular population
  • 60 % of patients with atrial fibrillation suffer from OSA
  • 50 % of patients with hypertension suffer from OSA
  • OSA is associated with increased blood pressure, 45% essential and 80% refractory hypertension

Screening is Simple

Due to the high prevalence of Obstructive Sleep Apnea among the cardiology population, screening is simple, quick and effective using our OSA Screening Tool.  There is no need for expensive screening tests to substitute for the 2-3 minutes it takes to ask your patient a few simple questions.  Our experience has shown that our tool is very effective and serves as a vehicle for ordering a sleep study.

Conditions that require an immediate sleep study

  • Witnessed apneas
  • Nocturnal arrhythmias
  • Nocturnal ischemia
  • Difficult to control hypertension requiring 3 or more medications
  • Family history of premature death in sleep

SCIENTIFIC ARGUMENTS

  • In 2005 treating cardiovascular disease cost $394 billion 1
  • The American Heart Association recommends screening for Sleep Disordered Breathing in patients who present with HF 2
  • Treating OSA decreases morbidity and mortality 3
  • Patients with even mild OSA are three times more likely to develop new hypertension 4
  • The Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure has named OSA a leading cause of hypertension. 5
  • Treating OSA alleviates hypertension 6
  • Patients with CAD have more severe pulmonary hypertension with concomitant OSA 7
  • Atrial fibrillation patients have a recurrence rate of 82%, if their sleep disordered breathing is left untreated 8
  • The presence of OSA confers a 2.4-fold increase in the diagnosis of heart failure 9
  • Patients with left ventricular systolic dysfunction have as much as a 40% prevalence of OSA 10
  • After effective treatment of OSA, the incidence of cardiovascular disease decreases 11

 ECONOMIC BENEFITS

There is strong medical incentive to diagnose and treat your patients for sleep disordered breathing, but what are the economic implications?

  • An investment of between $50,000 and $100,000 can yield income in excess of $250,000 or more annually
  • A fully operational sleep lab can be up and running in 90 days
  • Income will vary based on the size of you lab and your involvement in patient care including follow-up and treatment
















 LEARN MORE

Please contact us and we will be happy to provide your team with a free on site review and analysis.

        Healthy Heart Sleep Programs, Inc.
        210 Quincy Ave
        Brockton, MA 02302
        Phone: 877- YB TIRED (928-4733)
        Fax: 781-634-0457
        Email: contact@healthyheartsleep.com
 
















References

  1. American Heart Association.  Heart Disease and Stroke Statistics – 2005 Update. Dallas, TX. American Heart Association:2005
  2. Hunt SA, Abraham WT, Chin MH,Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michel K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/failure//index.pdf.
  3. Javaheri, S, MD, FACCP, Abraham, MD, FACC Cardiovascular Consequences of Obstructive Sleep Apnea.  McMahon Publishing Group 2005
  4. Peppard PE, Young T, Palta M, Skatrud J Prospective study of the association between sleep-disordered breathing and hypertension.  N Engl J Med 2000;342:1378-1384
  5. Chobanion AV, et alNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of Blood Pressure; The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; the JNC7 report, JAMA 2003;289:2560-2572
  6. Faccenda JF, Mackay TW, Boon NA. Randomized placebo-controlled trial of continuous positive airway pressure in the sleep apnea syndrome. Am J Respir Crit Care Med 2001:163:344-348
  7. Young T, Javaheri S Systemic and pulmonary hypertension in obstructive sleep apnea. In:Kryger M, RothT, Dement WC, eds. Principles and Practices of Sleep Medicine. 4th Ed Philadelphia, PA; Elsevier;2005:1192-1202
  8. Kanagala R, Murali NS, Friedman PA, et al Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003:107:2589-2594
  9. Shahar E, Whitney CW, Redline S, et al Sleep disordered breathing and cardiovascular disease: cross sectional results of the Sleep Heart Health study. Am J Respir Crit Care Med 2001:163:19-25
  10. Javaheri S, Sleep Disorders in systolic heart failure: a prospective study of 100 male patients. Int J Cardiol In press
    Sin DD, Fitzgerald F, Parker JD, Newton G, Flora JS, Bradley D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure Am J Respir Crit Care Med 1999:160:1101-1106
  11. Peker Y, Hedner J, Norum J, Kraiczi H. Increased incidence of cardiovascular disease in middle aged men with obstructive sleep apnea: a 7 year follow up. AM J  Respir Crit Care Med. 2002:166:159-165

 

  

Home I About Us I Employment I Labs I Contact I Privacy I Employee Intranet I WebMail Login

   Copyright © 2004-2008, Healthy Heart Sleep Programs, Inc.  I   A Healthy Heart Needs a Good Night's Sleep